NuVasive's net sales in the second quarter increased 44.8 percent year over year to $294.8 million, and clinical evaluations of its Pulse spine system got underway in Europe.
Spinal Tech
Stryker plans to hone in on smaller mergers and acquisitions as part of its strategy for short-term growth, according to CEO Kevin Lobo.
Degenerative disc disease patients who underwent total disc replacement with the ActivL Artificial Disc had better outcomes than patients who received the ProDisc-L, according to a study by Aesculap Implant Systems.
NuVasive's newest spine implant and four more updates from device companies in the last week:
Stryker posted $1.6 billion in net sales for its orthopedics business in the second quarter, and the company saw growth across all orthopedic procedure types.
Advertisement
The wife of an Indiana man who died of tuberculosis after receiving Aziyo Biologics' recalled allograft is suing the company.
Flowood, Miss.-based Zavation Medical Products was sold to a new private-equity firm, according to a July 22 news release.
NuVasive has launched its Modulus anterior lateral interbody fusion implant, the company announced July 22.
German medical device company Joimax is partnering with California-based contract resource organization North American Science Associates to bring support for prior authorization of Joimax’s devices and appeals processes to its U.S. customers.
Johnson & Johnson's orthopedics second-quarter sales increased 53.4 percent to $2.2 billion year over year with the company's spine sales seeing a return to global growth.